Dr. Hedva Voliovitch, MD, PH.D, M.B.A.

Chair and co- founder of the Israeli Society for HealthTech, Served as Senior Vice President for Global Pharmacovigilance and patient safety in Teva Pharmaceutical. Over  21 years of experience in global pharmacovigilance, innovative and generic  R&D and working with authorities around the world. Holds a degree in medicine from Tel Aviv University with a specialty in Internal Medicine, a PhD in philosophy from the Weizmann Institute of Molecular Biology and an MBA in Global Business from the Interdisciplinary Center Herzilya.